Sysmex (OTCMKTS:SSMXY) Reaches New 1-Year Low at $15.68

Sysmex Co. (OTCMKTS:SSMXY) hit a new 52-week low during mid-day trading on Monday . The stock traded as low as $15.68 and last traded at $15.70, with a volume of 96602 shares trading hands. The stock had previously closed at $16.01.

Sysmex Price Performance

The company’s 50 day moving average price is $17.63 and its 200-day moving average price is $17.52. The company has a market capitalization of $9.87 billion, a PE ratio of 31.32 and a beta of 0.66. The company has a current ratio of 3.10, a quick ratio of 2.27 and a debt-to-equity ratio of 0.10.

Sysmex (OTCMKTS:SSMXY) last announced its quarterly earnings results on Friday, February 9th. The company reported $0.13 earnings per share for the quarter, missing analysts’ consensus estimates of $0.16 by ($0.03). Sysmex had a return on equity of 11.15% and a net margin of 10.25%. The business had revenue of $770.84 million for the quarter. On average, sell-side analysts forecast that Sysmex Co. will post 0.53 earnings per share for the current fiscal year.

About Sysmex

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.